Amidate Injection, Solution
Product Images NDC 0409-6695

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amidate (NDC 0409-6695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Amidate 01)

Chemical Structure (Amidate 01)
Chemical structure of Etomidate, showing its molecular components including an imidazole ring, ester linkage, and phenyl group, corresponding to the active ingredient in Amidate 2 mg/mL injection solution by Hospira, Inc.*
FDA Label Image

Logo (Amidate 02)

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Label for Amidate Etomidate Injection, USP 20 mg/10 mL (2 mg/mL) in a 10 mL single-dose fliptop vial. It is for intravenous use only, distributed by Hospira, Inc. The label states it contains 2 mg of etomidate per mL, with propylene glycol 35% v/v, sterile and nonpyrogenic, and notes usual dosage instructions and disposal of unused portions. NDC 0409-6695.*
FDA Label Image

Principal Display Panel (10 mL Vial Tray)

Principal Display Panel (10 mL Vial Tray)
Packaging label for Amidate (etomidate) Injection, USP, 20 mg/10 mL (2 mg/mL) intravenous solution by Hospira, Inc. The label indicates a 10 mL single-dose fliptop vial with 10 units per package and includes the NDC 0409-6695-01. Storage and usage instructions are also present on the label.*
FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Label for Amidate (etomidate) Injection, USP 40 mg/20 mL (2 mg/mL) solution for intravenous use. The 20 mL single-dose fliptop vial is distributed by Hospira, Inc. The label includes dosage information, NDC 0409-6695-12, and states the product is sterile and nonpyrogenic.*
FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Principal Display Panel (20 mL Vial Tray)
Packaging label for Amidate 40 mg/20 mL (2 mg/mL) Etomidate Injection, USP in a single-dose fliptop vial. The label shows intravenous injection solution by Hospira, Inc. It includes dosage strength, quantity, NDC 0409-6695-02, and storage instructions. The label is primarily white with blue and black text and features the Hospira logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.